These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 31637536

  • 1. Ubiquitin-specific peptidase 39 regulates the process of proliferation and migration of human ovarian cancer via p53/p21 pathway and EMT.
    Yan C, Yuan J, Xu J, Zhang G, Li X, Zhang B, Hu T, Huang X, Mao Y, Song G.
    Med Oncol; 2019 Oct 21; 36(11):95. PubMed ID: 31637536
    [Abstract] [Full Text] [Related]

  • 2. USP39 promotes ovarian cancer malignant phenotypes and carboplatin chemoresistance.
    Wang L, Chen T, Li X, Yan W, Lou Y, Liu Z, Chen H, Cui Z.
    Int J Oncol; 2019 Jul 21; 55(1):277-288. PubMed ID: 31180526
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. USP39 mediates p21-dependent proliferation and neoplasia of colon cancer cells by regulating the p53/p21/CDC2/cyclin B1 axis.
    Yuan J, Li X, Zhang G, Cheng W, Wang W, Lei Y, Ma Q, Song G.
    Mol Carcinog; 2021 Apr 21; 60(4):265-278. PubMed ID: 33634905
    [Abstract] [Full Text] [Related]

  • 5. Knockdown of USP39 induces cell cycle arrest and apoptosis in melanoma.
    Zhao Y, Zhang B, Lei Y, Sun J, Zhang Y, Yang S, Zhang X.
    Tumour Biol; 2016 Oct 21; 37(10):13167-13176. PubMed ID: 27456357
    [Abstract] [Full Text] [Related]

  • 6. Knockdown of ubiquitin‑specific peptidase 39 inhibits the malignant progression of human renal cell carcinoma.
    Xu Y, Zhu MR, Zhang JY, Si GM, Lv JJ.
    Mol Med Rep; 2018 Mar 21; 17(3):4729-4735. PubMed ID: 29328477
    [Abstract] [Full Text] [Related]

  • 7. Ubiquitin-specific protease 39 is overexpressed in human lung cancer and promotes tumor cell proliferation in vitro.
    Lin Z, Xiong L, Lin Q.
    Mol Cell Biochem; 2016 Nov 21; 422(1-2):97-107. PubMed ID: 27629785
    [Abstract] [Full Text] [Related]

  • 8. Knockdown of ubiquitin-specific peptidase 39 inhibited the growth of osteosarcoma cells and induced apoptosis in vitro.
    Gan Z, Han K, Lin S, Hu H, Shen Z, Min D.
    Biol Res; 2017 Apr 12; 50(1):15. PubMed ID: 28403900
    [Abstract] [Full Text] [Related]

  • 9. USP39 promotes the growth of human hepatocellular carcinoma in vitro and in vivo.
    Yuan X, Sun X, Shi X, Jiang C, Yu D, Zhang W, Guan W, Zhou J, Wu Y, Qiu Y, Ding Y.
    Oncol Rep; 2015 Aug 12; 34(2):823-32. PubMed ID: 26081192
    [Abstract] [Full Text] [Related]

  • 10. USP39 regulates the cell cycle, survival, and growth of human leukemia cells.
    Liu C, Yao X, Li M, Xi Y, Zhao L.
    Biosci Rep; 2019 Apr 30; 39(4):. PubMed ID: 30898977
    [Abstract] [Full Text] [Related]

  • 11. USP39, a direct target of microRNA-133a, promotes progression of pancreatic cancer via the AKT pathway.
    Cai J, Liu T, Huang P, Yan W, Guo C, Xiong L, Liu A.
    Biochem Biophys Res Commun; 2017 Apr 22; 486(1):184-190. PubMed ID: 28286270
    [Abstract] [Full Text] [Related]

  • 12. Lentivirus mediated silencing of ubiquitin specific peptidase 39 inhibits cell proliferation of human hepatocellular carcinoma cells in vitro.
    Pan Z, Pan H, Zhang J, Yang Y, Liu H, Yang Y, Huang G, Ni J, Huang J, Zhou W.
    Biol Res; 2015 Mar 19; 48(1):18. PubMed ID: 25889525
    [Abstract] [Full Text] [Related]

  • 13. Lentivirus-mediated inhibition of USP39 suppresses the growth of gastric cancer cells via PARP activation.
    Wang X, Yu Q, Huang L, Yu P.
    Mol Med Rep; 2016 Jul 19; 14(1):301-6. PubMed ID: 27175747
    [Abstract] [Full Text] [Related]

  • 14. Ubiquitin-specific peptidase 39 promotes human glioma cells migration and invasion by facilitating ADAM9 mRNA maturation.
    Xiao Y, Ma W, Hu W, Di Q, Zhao X, Ma X, Chen X, Sun P, Wu H, Wu Z, Chen W.
    Mol Oncol; 2022 Jan 19; 16(2):388-404. PubMed ID: 33811456
    [Abstract] [Full Text] [Related]

  • 15. METTL3 promotes ovarian carcinoma growth and invasion through the regulation of AXL translation and epithelial to mesenchymal transition.
    Hua W, Zhao Y, Jin X, Yu D, He J, Xie D, Duan P.
    Gynecol Oncol; 2018 Nov 19; 151(2):356-365. PubMed ID: 30249526
    [Abstract] [Full Text] [Related]

  • 16. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
    Bugide S, Gonugunta VK, Penugurti V, Malisetty VL, Vadlamudi RK, Manavathi B.
    Cell Oncol (Dordr); 2017 Apr 19; 40(2):133-144. PubMed ID: 28039608
    [Abstract] [Full Text] [Related]

  • 17. USP39 Promotes the Viability and Migration of Head and Neck Squamous Cell Carcinoma Cell by Regulating STAT1.
    Hu Y, Wang Y, Hu W, Hu C, Wang B, Liu C, Deng A, Shen B, Wu K, Liu Y.
    Technol Cancer Res Treat; 2024 Apr 19; 23():15330338241250298. PubMed ID: 38706215
    [Abstract] [Full Text] [Related]

  • 18. Proteomic analysis of ovarian cancer cells during epithelial-mesenchymal transition (EMT) induced by epidermal growth factor (EGF) reveals mechanisms of cell cycle control.
    Grassi ML, Palma CS, Thomé CH, Lanfredi GP, Poersch A, Faça VM.
    J Proteomics; 2017 Jan 16; 151():2-11. PubMed ID: 27394697
    [Abstract] [Full Text] [Related]

  • 19. Epac1 knockdown inhibits the proliferation of ovarian cancer cells by inactivating AKT/Cyclin D1/CDK4 pathway in vitro and in vivo.
    Gao M, Ma Y, Bast RC, Li Y, Wan L, Liu Y, Sun Y, Fang Z, Zhang L, Wang X, Wei Z.
    Med Oncol; 2016 Jul 16; 33(7):73. PubMed ID: 27277757
    [Abstract] [Full Text] [Related]

  • 20. Overexpression of USP39 predicts poor prognosis and promotes tumorigenesis of prostate cancer via promoting EGFR mRNA maturation and transcription elongation.
    Huang Y, Pan XW, Li L, Chen L, Liu X, Lu JL, Zhu XM, Huang H, Yang QW, Ye JQ, Gan SS, Wang LH, Hong Y, Xu DF, Cui XG.
    Oncotarget; 2016 Apr 19; 7(16):22016-30. PubMed ID: 26959883
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.